Back

Real-world applicability of DanGer Shock trial criteria in a cardiac intensive care unit

9 May 2026 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Management and prognosis of cardiogenic shock and acute decompensated heart failure Cardiogenic Shock HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mariana Duarte Almeida

Hospital Center Tondela Viseu, Viseu (Portugal)

6 More presentations in this session

Presentation thumbnail
External validation of organ perfusion pressure as a prognostic marker in cardiogenic shock
Doctor P. Bocchino (Turin, IT)
Abstract Slides
Presentation thumbnail
Timing matters: early furosemide administration and mortality in acute heart failure
Mr D. Ferreira (Lisbon, PT)
Abstract Slides
Presentation thumbnail
External validation of the EHMRG30-ST score for short-term mortality risk stratification in European ADHF patients
Mr A. Mkrtchjan (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Major bleeding and mortality in cardiogenic shock: insights from the SMART-RESCUE II shock registry
Doctor J. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Vasodilator use and diuresis among patients admitted for an acute decompensation of heart failure. Preliminary results from the multicenters FOCUS-ADHF study
Doctor M. Bertaina (Turin, IT)
Abstract Slides

Access the full session

Session thumbnail
Management and prognosis of cardiogenic shock and acute decompensated heart failure

The Event

Event poster

Heart Failure 2026

9 May 2026 14:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources